CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
Why the Pediatric Workforce Crisis Demands Federal Action
A congressional briefing highlighted how workforce shortages are threatening children’s access to care.
July 22, 2026
Medicaid: The History of Children’s Health
Learn what the public health insurance program’s past can teach us about the future for America’s kids.
July 21, 2026
CHA Responds to Medicaid State Directed Payment Proposed Rule
The comments outline key recommendations to mitigate the impact of the H.R. 1 Medicaid cuts on children’s health.
July 21, 2026
